Aarkstore - Liver Fibrosis - Pipeline Review, H2 2014

Aarkstore Enterprise Aarkstore Enterprise

Description

‘Liver Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Liver Fibrosis’s therapeutic pipeline.
For more details : http://goo.gl/Z9r8KH

Informations

• Publié par: Shubhangi
• Publié le: 07 mai 2015
• Nombre de lectures: 0
• Langue: English

Extrait

Aarkstore Enterprise

Aarkstore - Liver Fibrosis - Pipeline Review, H2 2014

Browse Full Report @

http://www.aarkstore.com/pharmaceuticals-healthcare/63088/liver-fibrosis-pipeline- review

Summary

Published:166Oct 2014 | Pages

PDF :$ 2000 | Site Licence: $ 4000 | Enterprise Wide Licence : $ 6000

‘Liver Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Liver Fibrosis’s therapeutic pipeline.

ThisMarket Research Reportprovides comprehensive information on the therapeutic development for Liver Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Fibrosis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry- specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to

Aarkstore Enterprise

gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Liver Fibrosis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Liver Fibrosis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Liver Fibrosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Liver Fibrosis pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Liver Fibrosis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Liver Fibrosis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Aarkstore Enterprise

Order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/63088/liver-fibrosis-pipeline- review

Table of Contents:

Introduction 7 Global Markets Direct Report Coverage 7 Liver Fibrosis Overview 8 Therapeutics Development 9 Pipeline Products for Liver Fibrosis - Overview 9 Pipeline Products for Liver Fibrosis - Comparative Analysis 10 Liver Fibrosis - Therapeutics under Development by Companies 11 Liver Fibrosis - Therapeutics under Investigation by Universities/Institutes 14 Liver Fibrosis - Pipeline Products Glance 16 Clinical Stage Products 16 Early Stage Products 17 Liver Fibrosis - Products under Development by Companies 18 Liver Fibrosis - Products under Investigation by Universities/Institutes 21 Liver Fibrosis - Companies Involved in Therapeutics Development 22 ACROVIS biostructures GmbH 22 Advinus Therapeutics Ltd. 23 Angion Biomedica Corp. 24 BiOrion Technologies B.V. 25 Celgene Corporation 26 Digna Biotech, S.L. 27 FibroGen, Inc. 28 Galectin Therapeutics, Inc. 29 Genfit SA 30 GenKyoTex S.A. 31 Gilead Sciences, Inc. 32 GNI Group Ltd. 33 La Jolla Pharmaceutical Company 34 LG Life Sciences, Ltd. 35 Nitto Denko Corporation 36 Pfizer Inc. 37 Pharmaxis Limited 38 Promedior, Inc. 39 List Of Tables

Aarkstore Enterprise

Number of Products under Development for Liver Fibrosis, H2 2014 12 Number of Products under Development for Liver Fibrosis - Comparative Analysis, H2 2014 13 Number of Products under Development by Companies, H2 2014 15 Number of Products under Development by Companies, H2 2014 (Contd..1) 16 Number of Products under Investigation by Universities/Institutes, H2 2014 18 Comparative Analysis by Clinical Stage Development, H2 2014 19 Comparative Analysis by Early Stage Development, H2 2014 20 Products under Development by Companies, H2 2014 21 Products under Development by Companies, H2 2014 (Contd..1) 22 Products under Development by Companies, H2 2014 (Contd..2) 23

List Of Figures

Number of Products under Development for Liver Fibrosis, H2 2014 12 Number of Products under Development for Liver Fibrosis - Comparative Analysis, H2 2014 13 Number of Products under Development by Companies, H2 2014 14 Number of Products under Investigation by Universities/Institutes, H2 2014 17 Comparative Analysis by Clinical Stage Development, H2 2014 19 Comparative Analysis by Early Stage Products, H2 2014 20 Assessment by Monotherapy Products, H2 2014 49 Number of Products by Top 10 Targets, H2 2014 50 Number of Products by Stage and Top 10 Targets, H2 2014 50 Number of Products by Top 10 Mechanism of Actions, H2 2014 53

Related Market Research reports:

         

Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014 Hematological Tumor - Pipeline Review, H1 2014 Inflammation - Pipeline Review, H1 2014 Opioid Induced Side Effects - Pipeline Review, H1 2014 Skin Infections - Pipeline Review, H1 2014 Restenosis - Pipeline Review, H1 2014 Tauopathies - Pipeline Review, H1 2014 Nasopharyngitis (Common Cold) - Pipeline Review, H1 2014 Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H1 2014 Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014

About Aarkstore Enterprise

Aarkstore Enterprise

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers

Contact Details:

Aarkstore Enterprise Phone: [phone] Email:[e-mail] Our Website:http://www.aarkstore.com Our Blog :http://www.aarkstore.com/blog/ Latest News :http://www.aarkstore.com/news Facebook:https://www.facebook.com/aarkstoredotcom